Intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in saliva

Directly measure the neutralizing antibody (NAb) presence, implying the protective immunity against virus

An aid in the Evaluation levels of human anti-novel coronavirus neutralizing antibody titer

Intended for in vitro qualitative detection to SARS-CoV-2 antigen in human nasopharyngeal swab or oropharyngeal swab samples.

Intended for qualitative detection of SARS-CoV-2 nucleocapsid antigen from Swab specimen.

Can be used for early screening of infection and is an effective supplement to nucleic acid (PCR) detection.

Anterior nasal swab specimen, noninvasive

A rapid chromatographic immunoassay for the qualitative detection

Presumptive detection of COVID-19 antigens from nasal or throat specimens within the first 7 days of symptom onset

Used for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in human throat swab and nasal swab samples

Use of the substance/preparation: In vitro diagnostic medical device.

Rapid & High-throughput Evaluation of Vaccination

Assisting in finding asymptomatic carriers and conducting serological surveys.

No special equipment and expertise needed.

The Most Suitable RDT to combat COVID-19

Advantages of Genrui Antigen Test Excellent selection of materials

High Accuracy, specificity and sensitivity.

Mutiple sample types are available to fit different population or testing policy.

The collection process is painless and won't cause any injury or discomfort to the human body.

Rapid, reliable, early and easy detection of COVID-19